The survival analyses performed for breast cancer patients revealed a similar 10-year survival prognosis when comparing the patients with ABCB1 G2677T/A or C3435T polymorphic variants (VV) versus wild and heterozygous variants (WV and WW) (Figure 1A,B). This evidence concerns the gene ABCB1 and breast carcinoma.